These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
979 related articles for article (PubMed ID: 26587975)
1. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma. Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975 [TBL] [Abstract][Full Text] [Related]
2. HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL. Pathil A; Armeanu S; Venturelli S; Mascagni P; Weiss TS; Gregor M; Lauer UM; Bitzer M Hepatology; 2006 Mar; 43(3):425-34. PubMed ID: 16583461 [TBL] [Abstract][Full Text] [Related]
3. Anticancer activity of MPT0G157, a derivative of indolylbenzenesulfonamide, inhibits tumor growth and angiogenesis. Huang YC; Huang FI; Mehndiratta S; Lai SC; Liou JP; Yang CR Oncotarget; 2015 Jul; 6(21):18590-601. PubMed ID: 26087180 [TBL] [Abstract][Full Text] [Related]
4. Sorafenib and HDAC inhibitors synergize with TRAIL to kill tumor cells. Hamed HA; Yamaguchi Y; Fisher PB; Grant S; Dent P J Cell Physiol; 2013 Oct; 228(10):1996-2005. PubMed ID: 23674352 [TBL] [Abstract][Full Text] [Related]
5. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice. Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma. Lu YS; Kashida Y; Kulp SK; Wang YC; Wang D; Hung JH; Tang M; Lin ZZ; Chen TJ; Cheng AL; Chen CS Hepatology; 2007 Oct; 46(4):1119-30. PubMed ID: 17654699 [TBL] [Abstract][Full Text] [Related]
7. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells. Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914 [TBL] [Abstract][Full Text] [Related]
8. Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009. Hsieh IN; Liou JP; Lee HY; Lai MJ; Li YH; Yang CR Cell Death Dis; 2014 Apr; 5(4):e1166. PubMed ID: 24722291 [TBL] [Abstract][Full Text] [Related]
9. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation. Carlisi D; Lauricella M; D'Anneo A; Emanuele S; Angileri L; Di Fazio P; Santulli A; Vento R; Tesoriere G Eur J Cancer; 2009 Sep; 45(13):2425-38. PubMed ID: 19643600 [TBL] [Abstract][Full Text] [Related]
10. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068 [TBL] [Abstract][Full Text] [Related]
11. Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma. Srinivas C; Swathi V; Priyanka C; Anjana Devi T; Subba Reddy BV; Janaki Ramaiah M; Bhadra U; Bhadra MP Apoptosis; 2016 Nov; 21(11):1249-1264. PubMed ID: 27502208 [TBL] [Abstract][Full Text] [Related]
12. SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib. Emanuele S; Lauricella M; Carlisi D; Vassallo B; D'Anneo A; Di Fazio P; Vento R; Tesoriere G Apoptosis; 2007 Jul; 12(7):1327-38. PubMed ID: 17351739 [TBL] [Abstract][Full Text] [Related]
13. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation. Luan Z; He Y; He F; Chen Z Mol Med Rep; 2015 Jan; 11(1):203-11. PubMed ID: 25333816 [TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation. Borbone E; Berlingieri MT; De Bellis F; Nebbioso A; Chiappetta G; Mai A; Altucci L; Fusco A Oncogene; 2010 Jan; 29(1):105-16. PubMed ID: 19802013 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells. Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477 [TBL] [Abstract][Full Text] [Related]
16. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I. Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421 [TBL] [Abstract][Full Text] [Related]
17. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837 [TBL] [Abstract][Full Text] [Related]
18. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL. Yerbes R; López-Rivas A Invest New Drugs; 2012 Apr; 30(2):541-7. PubMed ID: 21107885 [TBL] [Abstract][Full Text] [Related]
19. Carnosic acid sensitized TRAIL-mediated apoptosis through down-regulation of c-FLIP and Bcl-2 expression at the post translational levels and CHOP-dependent up-regulation of DR5, Bim, and PUMA expression in human carcinoma caki cells. Jung KJ; Min KJ; Bae JH; Kwon TK Oncotarget; 2015 Jan; 6(3):1556-68. PubMed ID: 25596735 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21 Zhou H; Cai Y; Liu D; Li M; Sha Y; Zhang W; Wang K; Gong J; Tang N; Huang A; Xia J Cell Prolif; 2018 Jun; 51(3):e12447. PubMed ID: 29484736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]